A news item is in circulation with statements said to be made by Prof. Neelika Malavige reading;
- Many people believe that those who have been vaccinated with the Sinopharm vaccine will not be allowed to enter certain countries, but that this is untrue.
- The vaccine, manufactured in China, is registered with the World Health Organization (WHO), which makes it a reliable vaccine.
- The information on vaccines that must be obtained at the time of entry into certain countries are distorted,
The relevant news:
Upon fact-checking, we were able to uncover important information about the countries that accept the Sinopharm (BBIBP-CorV) vaccine along with its scientific approval and the vaccination requirements.
Sinopharm relies on the older but tested technology, which uses an inactivated form of the virus to stimulate the body’s immune response. This Chinese pharmaceutical product got the green signal from the WHO on 7 May 2021. So far, 53 countries, including Argentina, China, Lebanon, Pakistan, and Vietnam approve the vaccine.
Meanwhile, a total of 29 EU and EEA countries recognize all the vaccines that have been approved by the European Medicines Agency (EMA); Pfizer/BioNTech, Moderna, AstraZeneca, and Johnson & Johnson jabs as valid proof of immunization. In most cases, all those who have been vaccinated with an EMA-approved jab are permitted restriction-free entry to the countries mentioned above.
However, some countries still place minor restrictions against travelers, while others permit entry even to those immunized with a vaccine other than the ones mentioned above. This means that except for the vaccines that EMA has approved, several countries also recognize the vaccines that are on the World Health Organization’s (WHO) Emergency Use Listing.
According to a new tool developed by VisaGuide.World, which helps travelers find out whether the country they plan on visiting accepts their COVID-19 vaccine as valid proof, the three vaccines that are most recognized in the world after the EMA ones are Covishield, Sinopharm, and Sinovac.
In addition, the professor herself confirms that the data presented in this news is not stated by her and that she has not participated in any press conference or other related program to talk about the Sinopharm vaccine’s validity or how it affects upon traveling across borders. She has made no statement regarding this and the information circulating about this vaccine being distorted.
It is conclusive that she has not made statements about the Sinopharm vaccine affecting traveling borders, or the validity of the vaccine, or that the information about this vaccine is distorted.